BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sanjay Popat, PhD, MBBS
Royal Marsden NHS Foundation Trust
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Leuven
Leuven, Belgium
- Chu Liege
Liège, Belgium
- Unicancer - Institut Bergonie
Bordeaux, France
- Caen- Chu
Caen, France
- Le Mans - Chg
Le Mans, France
- Lyon - Centre Léon Bérard
Lyon, France
- Hospital Nord
Marseille, France
- Curie Cancer Center Paris
Paris, France
- Toulouse - Chu
Toulouse, France
- Tours - Chu
Tours, France
- Ss Antonio E Biagio E Cesare Arrigo Hospital
Alessandria, Italy
- Irccs Instituto Tumori Giovanni Paolo Ii
Bari, Italy
- Fondazione Irccs Istituto Nazionale Die Tumori
Milan, Italy
- Instituto Europeo Di Oncologia (ieo)
Milan, Italy
- Aulss2 Marca Trevigiana Treviso
Treviso, Italy
- University Hospital of Turin
Turin, Italy
- Alicante University Hospital Isabial
Alicante, Spain
- Ico Hospitalet
Barcelona, Spain
- Vall Hebron University Hospital/vall Hebron Institue Oncology
Barcelona, Spain
- Puerta de Hierro Hospital
Majadahonda, Spain
- Hospital Parc Tauli Sabadell
Sabadell, Spain
- Virgen del Rocio
Seville, Spain
- Complexo Hospitalario Universitario de Vigo
Vigo, Spain
- Kantonsspital Aarau
Aarau, Switzerland
- Istituto Oncologica Della Svizzera Italiana
Bellinzona, Switzerland
- Ferdinando Cerciello
Bern, Switzerland
- Kantonsspital Graubünden
Chur, Switzerland
- Chuv
Lausanne, Switzerland
- Luzerner Kantonsspital
Lucerne, Switzerland
- Kantonsspital St. Gallen
Sankt Gallen, Switzerland
- Kantonsspital Winterthur
Winterthur, Switzerland
- Universitätspital Zürich
Zurich, Switzerland
- Addenbrooke'S Hospital
Cambridge, United Kingdom
- Clatterbridge Cancer Centre
Liverpool, United Kingdom
- Guy'S and St Thomas' Hospital
London, United Kingdom
- Royal Marsden Hospital (fulham Road)
London, United Kingdom
- Royal Marsden Hospital (sutton)
London, United Kingdom
- Kent Oncology Centre
Maidstone, United Kingdom
- Wythenshawe Hospital
Manchester, United Kingdom
- Plymouth Hospitals Nhs Trust
Plymouth, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2019
- Primary completion
- 1 Sept 2023
- Completion
- 18 Nov 2024
- Last update posted
- 14 May 2026
- Registered enrollment
- 400
- Registry id
- NCT03762018
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.